- Hypertrophic Cardiomyopathy (HCM)
- Vaccines: 2023 Year in Review
- Eyecare
- Urothelial Carcinoma
- Women's Health
- Hemophilia
- Heart Failure
- Vaccines
- Neonatal Care
- NSCLC
- Type II Inflammation
- Substance Use Disorder
- Gene Therapy
- Lung Cancer
- Spinal Muscular Atrophy
- HIV
- Post-Acute Care
- Liver Disease
- Pulmonary Arterial Hypertension
- Biologics
- Asthma
- Atrial Fibrillation
- Type I Diabetes
- RSV
- COVID-19
- Cardiovascular Diseases
- Breast Cancer
- Prescription Digital Therapeutics
- Reproductive Health
- The Improving Patient Access Podcast
- Blood Cancer
- Ulcerative Colitis
- Respiratory Conditions
- Multiple Sclerosis
- Digital Health
- Population Health
- Sleep Disorders
- Biosimilars
- Plaque Psoriasis
- Leukemia and Lymphoma
- Oncology
- Pediatrics
- Urology
- Obstetrics-Gynecology & Women's Health
- Opioids
- Solid Tumors
- Autoimmune Diseases
- Dermatology
- Diabetes
- Mental Health
Plans focus on star ratings in light of ACA pay cuts
Payment cuts to Medicare Advantage prompt plans to narrow their networks.
UnitedHealthcare, Humana and other plans have sent mass termination notices to their provider partners, indicating that Affordable Care Act (ACA) payment cuts to Medicare Advantage have forced their hand in making reduction to their networks. More than $200 billion in payment cuts are expected.
“What United is doing is narrowing their network to reduce the amount of contracts and really focus their efforts on the providers that’ll work with them to help them improve their star ratings,” says Don Hall, principal, Delta Sigma LLC, in Littleton, Colo., and MHE editorial advisor. “For a plan that has a large network, they’re not going to be able to control that network nearly as well. High quality can be achieved by focusing on the providers that are willing to work together to provide the appropriate information, communicate and so on-they’re going to be critical to a good star rating."
Narrow networks are already an industry trend, he says, adding that Accountable Care Organizations (ACOs) are narrow networks by definition. According to Hall, plans will be requiring their narrow networks to have better communication and to be more attentive to certain protocols and procedures. Although providers nationwide are going through appeals processes in order to force insurers to reconsider, Halls says that providers are actually in a position to determine what networks they want to be part of and to understand the specifics of what risks are required to be part of a specific network.
“Providers need to determine where they want to fall in all of this,” he says. “Going forward, we’re going to see much more replacement of large networks with narrower networks. It’s a reality that’s coming.”
Upended: Can PBM Transparency Succeed?
March 6th 2024Simmering tensions in the pharmacy benefit management (PBM) industry have turned into fault lines. The PBMs challenging the "big three" have formed a trade association. Purchaser coalitions want change. The head of the industry's trade group says inherent marketplace friction has spilled over into political friction.
Read More
In this episode of the "Meet the Board" podcast series, Briana Contreras, Managed Healthcare Executive editor, speaks with Ateev Mehrotra, a member of the MHE editorial advisory board and a professor of healthcare policy and medicine at Harvard Medical School. Mehtrotra is also a hospitalist at the Beth Israel Deaconess Medical Center in Boston. In the discussion, Contreras gets to know Mehrotra more on a personal level and picks his brain on some of his research interests including telehealth, alternative payment models and price transparency.
Listen
Inflation Reduction Act: Reforms to Patient Cost-Sharing
September 18th 2023Lower out-of-pocket costs for patients might put upward pressure on drug prices, as manufacturers face less price sensitivity, note Matthew Majewski and Rhett Johnson of Charles River Associates. But they also note that upward pressure on price is likely to be limited to the inflation rate as any additional price increase would need to be paid back to CMS in the form of inflation rebates.
Read More
Spending climbed by 2.7% in 2021. In 2020, it soared by 10.3%, fueled by federal government spending in response to the pandemic. The blizzard of calculations of 2021 healthcare spending by CMS’ actuaries also provides further evidence that utilization of healthcare services bounced back in 2021.
Read More
